Tatva Chintan Pharma Chem Ltd (TATVA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003512, "name": "Tatva Chintan", "stock_name": "Tatva Chintan", "full_name": "Tatva Chintan Pharma Chem Ltd", "name_url": "stocks-analysis/tatva-chintan", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,605.25", "chg": -21.3, "chgp": "-1.31%", "dir": -1, "prev_price": "1,626.55", "mcapval": "3,773.00 Cr", "mcap": "Small Cap", "scripcode": 543321, "symbol": "TATVA", "ind_name": "Specialty Chemicals", "ind_code": 11, "sector_id": 74, "indexname": "India SENSEX", "isin": "INE0GK401011", "curr_date": "Sep 01, 03:30 PM", "curr_time": "07:14 AM", "last_traded_at": "Sep 01, 03:30 PM IST", "bse_nse_vol": "38.15 k", "exc_status": "Active", "traded_date": "Sep 01, 2026", "traded_date_str": "2026 09 01", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tatva-chintan-1003512-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Tatva Chintan Pharma Chem Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-buy-4175985", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/TatvaChintanPha_mojoScore_4175985.png", "date": "2026-08-31 10:10:39", "description": "Tatva Chintan Pharma Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Tatva Chintan Pharma Chem Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-buy-4162440", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/TatvaChintanPha_mojoScore_4162440.png", "date": "2026-08-20 10:10:40", "description": "Tatva Chintan Pharma Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Tatva Chintan Pharma Chem Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-buy-4143991", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/TatvaChintanPha_mojoScore_4143991.png", "date": "2026-08-09 10:10:28", "description": "Tatva Chintan Pharma Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 August 2026, providing investors with the most up-to-date view of its performance and prospects." }, { "title": "Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1838.85", "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-hits-new-52-week-high-of-rs183885-4133272", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/TatvaChintanPha_priceRelatedfactors_4133272.png", "date": "2026-08-03 09:53:24", "description": "Surging to a fresh 52-week high of Rs 1838.85 on 3 Aug 2026, Tatva Chintan Pharma Chem Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 62.57% gain over the past year against the Sensex's decline of 2.44%." }, { "title": "Tatva Chintan Pharma Chem Ltd Gains 3.75%: 4 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-gains-375-4-key-factors-driving-the-weeks-momentum-4131412", "imagepath": "", "date": "2026-08-01 12:02:27", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> New 52-week high at Rs.1,832.80</p>\n <p><strong>28 Jul:</strong> Formation of Golden Cross signalling bullish breakout</p>\n <p><strong>29 Jul:</strong> Upgrade to Buy rating on strong technical and financial performance</p>\n <p><strong>31 Jul:</strong> Week closes at Rs.1,791.20 (+3.75%) outperforming Sensex</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,726.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..." }, { "title": "Tatva Chintan Pharma Chem Ltd Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4125361", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TatvaChintanPha_mojoScore_4125361.png", "date": "2026-07-29 08:35:36", "description": "Tatva Chintan Pharma Chem Ltd, a specialty chemicals small-cap, has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements in technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 28 July 2026, highlights the company’s robust quarterly results, bullish technical signals, and market-beating returns, positioning it favourably against peers and broader indices." }, { "title": "Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-technical-momentum-shifts-signal-bullish-outlook-4125185", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TatvaChintanPha_technicaldot_4125185.png", "date": "2026-07-29 08:04:03", "description": "Tatva Chintan Pharma Chem Ltd has witnessed a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by robust technical indicators such as MACD, Bollinger Bands, and moving averages, alongside impressive stock returns that outpace the broader Sensex over multiple time frames." }, { "title": "Golden Cross Confirmed: Do Tatva Chintan Pharma Chem Ltd's Other Technical Indicators Agree?", "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4124578", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TatvaChintanPha_goldencross_4124578.png", "date": "2026-07-28 18:00:46", "description": "The 50-day moving average has crossed above the 200-day moving average for Tatva Chintan Pharma Chem Ltd, signalling a golden cross on 28 Jul 2026. Yet, the stock declined 3.60% on the same day, and while weekly and monthly technical indicators mostly support the crossover, the mixed price action raises questions about the signal's strength." }, { "title": "Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1832.8", "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-hits-new-52-week-high-at-rs18328-4122889", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TatvaChintanPha_priceRelatedfactors_4122889.png", "date": "2026-07-27 15:38:20", "description": "With a decisive surge to Rs 1832.8 on 27 Jul 2026, Tatva Chintan Pharma Chem Ltd has reached a fresh 52-week high, marking a 58.51% gain over the past year and significantly outperforming the Sensex, which declined 5.68% in the same period. This milestone reflects a powerful momentum driven by a confluence of technical indicators aligning favourably across weekly and monthly timeframes." } ], "total": 522, "sid": "1003512", "stock_news_url": "https://www.marketsmojo.com/news/tatva-chintan-pharma-chem-1003512" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "28-Aug-2026", "details": "Newspaper Advertisement - Disclosure under Regulation 30 44 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended. (\"SEBI Listing Regulations\") - (Post Dispatch)", "source": "BSE" }, { "caption": "Notice Of The 30Th AGM Of The Members Of The Company Scheduled To Be Held On Friday 25 September 2026 At 04:00 P.M. (IST) Through Video Conferencing (\"VC\") / Other Audio Visual Means (\"OAVM\")", "datetime": "27-Aug-2026", "details": "Notice of the 30th AGM of the Members of the Company scheduled to be held on Friday 25 September 2026 at 4:00 p.m. (IST) through Video Conferencing (VC\") / Other Audio Visual Means (\"OAVN\")", "source": "BSE" }, { "caption": "Business Responsibility and Sustainability Reporting (BRSR)", "datetime": "27-Aug-2026", "details": "Pursuant to Regulation 34(2)(f) of the SEBI Listing Regulations we are submitting herewith the Business Responsibility and Sustainability Report (BRSR\") for FY 2025-26 which forms part of the Annual Report FY 2025-26.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Tatva Chintan Pharma Chem Ltd has declared <strong>20%</strong> dividend, ex-date: 11 Sep 26", "dt": "2026-09-11", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jul: New 52-week high at Rs.1,832.80

28 Jul: Formation of Golden Cross signalling bullish breakout

29 Jul: Upgrade to Buy rating on strong technical and financial performance

31 Jul: Week closes at Rs.1,791.20 (+3.75%) outperforming Sensex

Read full news article

Tatva Chintan Pharma Chem Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-07-29 08:35:36

Tatva Chintan Pharma Chem Ltd, a specialty chemicals small-cap, has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements in technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 28 July 2026, highlights the company’s robust quarterly results, bullish technical signals, and market-beating returns, positioning it favourably against peers and broader indices.

Read full news article

Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-29 08:04:03

Tatva Chintan Pharma Chem Ltd has witnessed a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by robust technical indicators such as MACD, Bollinger Bands, and moving averages, alongside impressive stock returns that outpace the broader Sensex over multiple time frames.

Read full news article

Golden Cross Confirmed: Do Tatva Chintan Pharma Chem Ltd's Other Technical Indicators Agree?

2026-07-28 18:00:46

The 50-day moving average has crossed above the 200-day moving average for Tatva Chintan Pharma Chem Ltd, signalling a golden cross on 28 Jul 2026. Yet, the stock declined 3.60% on the same day, and while weekly and monthly technical indicators mostly support the crossover, the mixed price action raises questions about the signal's strength.

Read full news article

Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1832.8

2026-07-27 15:38:20

With a decisive surge to Rs 1832.8 on 27 Jul 2026, Tatva Chintan Pharma Chem Ltd has reached a fresh 52-week high, marking a 58.51% gain over the past year and significantly outperforming the Sensex, which declined 5.68% in the same period. This milestone reflects a powerful momentum driven by a confluence of technical indicators aligning favourably across weekly and monthly timeframes.

Read full news article

Tatva Chintan

Tatva Chintan Pharma Chem Ltd is Rated Buy

Tatva Chintan Pharma Chem Ltd is Rated Buy

Tatva Chintan Pharma Chem Ltd is Rated Buy

Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1838.85

Tatva Chintan Pharma Chem Ltd Gains 3.75%: 4 Key Factors Driving the Week’s Momentum

Key Events This Week

Tatva Chintan Pharma Chem Ltd Upgraded to Buy on Strong Technical and Financial Performance

Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Signal Bullish Outlook

Golden Cross Confirmed: Do Tatva Chintan Pharma Chem Ltd's Other Technical Indicators Agree?

Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1832.8

Announcement under Regulation 30 (LODR)-Newspaper Publication

Notice Of The 30Th AGM Of The Members Of The Company Scheduled To Be Held On Friday 25 September 2026 At 04:00 P.M. (IST) Through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM")

Business Responsibility and Sustainability Reporting (BRSR)

Corporate Actions